Skip to main content
Lunit Inc. logo

Lunit Inc. — Investor Relations & Filings

Ticker · 328130 ISIN · KR7328130000 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 317 across all filing types
Latest filing 2022-08-25 Regulatory Filings
Country KR South Korea
Listing KO 328130

About Lunit Inc.

https://www.lunit.io/

Lunit Inc. develops and provides advanced medical artificial intelligence (AI) software focused on cancer diagnostics and therapeutics. The company's core offering is a platform-based AI ecosystem designed to analyze and interpret medical data, including radiological images and pathology slides. Its solutions, such as the Lunit INSIGHT suite for mammography and chest X-ray analysis, assist healthcare professionals in the early detection of cancer, enhancing diagnostic accuracy and workflow efficiency. In precision oncology, Lunit's AI technology supports biomarker discovery and treatment response prediction by analyzing tissue pathology. The company also collaborates with biopharmaceutical partners to accelerate oncology drug development and create AI-powered companion diagnostics. Lunit's platform integrates multimodal data to provide actionable insights across the cancer care continuum, from screening to treatment.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)(인공지능 기반 유방촬영술(Mammography) 영상 진단 보조 소프트웨어 Lunit INSIGHT MMG의 대만 식품의약품청(Taiwan Food and Drug Administration; TFDA) 의료기기 제조판매허가 취득)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) from Lunit regarding the acquisition of a medical device manufacturing and sales license from the Taiwan Food and Drug Administration (TFDA) for their AI-based software, Lunit INSIGHT MMG. This is a regulatory announcement regarding company operations and product approvals that does not fit into specific categories like financial reports, dividends, or share transactions. Therefore, it is classified as a general regulatory filing.
2022-08-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as an 'Insider Trading Report' or 'Director's Dealing' report) where company executives or major shareholders disclose changes in their shareholdings. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2022-08-18 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for Lunit Inc. for the period ending June 30, 2022. It contains detailed financial data, business operations, management discussions, and capital structure information. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) that contains actual financial statements and analysis is classified as an Interim/Quarterly Report (IR). H1 2022
2022-08-12 Korean
기타경영사항(자율공시)(특허권 취득(의료 영상의 메타데이터 예측 장치 및 방법))
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure ('자율공시') from Lunit regarding the acquisition of a patent ('특허권 취득'). It details the patent name, the technology involved, and its strategic application. Since this is a regulatory disclosure of a specific corporate event that does not fit into financial reporting, M&A, or governance categories, it falls under the general regulatory filing category.
2022-08-11 Korean
기타경영사항(자율공시)(특허권 취득)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Lunit regarding the acquisition of a patent ('특허권 취득'). It follows the standard format for a voluntary disclosure ('자율공시') of a material business event in the Korean market. Since it does not fit into specific categories like financial reports, M&A, or shareholder meetings, it is classified as a general regulatory filing.
2022-08-02 Korean
본점소재지변경
Regulatory Filings Classification · 1% confidence The document is a short, formal announcement regarding a change in the company's registered office address (headquarters). It does not fit into financial reporting, shareholder voting, or specific corporate action categories like M&A or dividends. As it is a general regulatory announcement regarding corporate administrative changes, it falls under the fallback category for regulatory filings.
2022-07-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.